Anyone have thoughts on blackberry. Thanks

Nice movement in ANF today. Stock at multiyear lows and they're fielding buyout offers. Gotta love that.


NAK - Kerrisdale can suck it on this one.

Would like to short the ES in the area between 2397 and 2398, but given the dynamic I think I will call it a day soon

Seems hard to imagine shareholders selling for less than 1 X sales. But idk. Stocks at like 1/3 of sales. Bought some. Long FEYE here. Short timeframe breakout anticipation. Strong revenue growth. Thats all that matters in this current market.

Hyachahchachha

Been wanting to buy snap jan18 puts before earnings but my bank is taking forever to upgrade my trading account (even tried today but couldn't yet). Looks like I missed a good trade there

I would say that they matter quite a bit, yes. Lots of information to be disclosed. You don't think quarterly earnings on XON matter "even the slightest bit"?

In reference to quote about IMUN....

"Really poorly pump and dump"

Actually, you are completely off. Please don't respond if you've looked at it for 5 minutes, and think you have any evidence of it being pump and dump based on preconceived notions you have about penny stocks or something else that you just looked over briefly without actually digging all the way into it.

Read EVERY SINGLE 8-k this year that discusses debt restructurings, read through all 3 sticky notes on the IMUN message board from Investors Hub, do your complete due diligence, and then come back and tell me its a pump and dump.

And if you still think so, please explain the reason why you think that. Please don't just write something if you can't back it up. There are no pumps/emails, any of that. Not sure what makes you think its a pump and dump. This is a very quiet company, that has experienced massive delays in getting to commercialization for their wonder drug (low dose naltrexone), has taken on toxic financing that torched the stock even more, and if you read the 8-k's this year, you will see that the toxic financing and dilution are a thing of the past, and this stock is heading straight up. The timing was perfect maybe a month ago when it was .03, but the timing will continue to be great as it will keep going up from here on out IMO. Stock is around .07 currently.

I am the cousin that recommended the stock to my cousin from DaHardRock's post on IMUN... (my cousin doesn't know how to look into things himself from my recommendation, so asks others to research it for him)...I am only responding here because my cousin asked me to do so as well.

Anybody who knows how to do due diligence on a company, and is willing to put the time into doing their due diligence on IMUN, will find a true gem that is about to erupt in the next few months (as soon as they hit commercialization) IN MY OPINION.

Disclaimer: this is not investment advice

+1000.

I base it on looking at what they're trying to sell - a low dose version of an opioid antagonist as a treatment for AIDS. I've looked a lot of pump and dump bio but this one takes the cake for not even trying to look real. It's farcical. There's not even a plausible mechanism of action.

Hence why they're trying to get this clownshow approved in NIGERIA with non-blinded trials (zero possibility for fraud or bribery there).

You can tell in 5 minutes that it's a brain dead pump and dump. No further research necessary.

Ahahahaha. Evidence of "wonder drug"? The studies they've done are worthless. There's no mechanism of action. If it's so "wonderful", why aren't they partnering with someone and getting it approved some non-clownish place other than Nigeria, where actual money can be made? Nigeria? Come on man.
Here's where you destroy your (tiny) credibility. I mean, we literally have proof of more dilution and possibly predatory lending right here in their filing from 3 days ago:



Would it be this Ira Gaines, or is that just a wild coincidence?

Plenty more at the link.
Tell your cousin to get a new cousin. Or at least stop listening to you. They're not even trying here; this is one of the worst and most transparent pump and dumps I've seen when it comes to pennies.
Just absurd. Tell your cousin to stop listening, ever, to anything you say about investing or speculating.

edit: alternatively, tell your cousin I have an excellent investment opportunity in Mars Colony bonds, for the upcoming trip. He can PM me for details/the money transfer.

"tell your cousin to get a new cousin".

Wow that was hilarious.

ya that's a quality zinger

I read your response and will respond to everything either late tonight or tomorrow morning. Busy now. Please check back.

In the mean time, you can go to www.lowdosenaltrexone.org to get more info on the credibility of the drug, or go to Amazon and search "low dose naltrexone" under books to see various books about Low dose naltrexone that have very positive reviews. Or can search for low dose naltrexone on YouTube for very informative videos on LDN.

I will give links tomorrow.

Why don't you two just make a wager? It's what we all want to see.

Oh SNAP

Here's the problem. Everything from cow piss to vibrations to homeotherapy to insulin shock therapy has a long list of devoted adherents, including prominent doctors, and published peer reviewed research to back it up.

The trouble is, it's bull****. Let's take a little sanity test, shall we? This is what your website claims that a low dose of opioid antagonist can achieve:



If that doesn't set alarm bells ringing, you lack the understanding/mental capacity/epistemological sophistication needed to not lose your shirt in biotech investing. Any one drug that's claimed to work for HIV, depression, the common cold, breast cancer and alzheimers is automatically 99.9% likely to be total bull****. And it's not close.

The website you linked was first registered in 1999. It is 18 years later, and not a single replicated clinical trial has shown it to beneficial for any of the long list of conditions that proponents claim it is beneficial for. This is truly extraordinary, for something that supposedly has significant clinical effect.

But let's put all that aside. Because it's ultimately irrelevant. Here's what the doctor who created the naltrexone website said:
So the very guy from your linnk says that there is no money in it (as there usually isn't in non-patentable generics). And that makes it a good thing to invest in...why?

This is what I mean about it being a low end pump and dump. It's not even clever. They've merely tagged onto a name that has some google-able details and books behind it, they hit up the forums and do things to get press releases out, and enough people think/do research as you do and swallow the BS that they keep doing secondaries and paying themselves handsome director's fees (they manage to spend $4 million/year, somehow!). It's legal theft, and it's very common; this isn't even a clever example.

But they're doing non-blinded studies in Nigeria, they have a drug for which there's no profit case, etc. Sounds like a home run.
You're really going to give me a Youtube video to explain why I should buy a biotech company trying for approval in Nigeria? While we're swapping youtube videos, here's another great wonder cure/investing idea with lots of adherents, including medical doctors:




What's the point? You've been unable to think critically about biotech. That's not a slur on you, it's extremely common to get caught up in quack medical claims pushed by books and websites.

For comparison, here's what would be a plausible investing thesis for this company:

- Low dose naltrexone is obviously total BS
- However, they're doing "clinical trials" in Nigeria and pushing for approval for AIDS
- The odds of them succeeding through bribery are moderately high
- At the same time, this "news" might coincide with a paid pump cycle; they might have partnered and sold stock to possible long time pumpers/fraudsters recently if you examine their filings.
- It's obviously a highly risky bet, but it might be possible to ride the pump cycle a little for an ok return if you can get out before it crashes when they do another secondary.

Now there's a speculative thesis I can get behind. Still thin, but at least 100% rational.

sounds like something worth wagering on Tooth!

Haven't read the conference call yet, but if it was like the last one no actual actionable information will be disclosed and the results don't matter because with development-stage biotech results can always be spun and the CMFIC of XON is a wonderful teller of tales.

Again, I have no opinion on this company as the value of an investment. I think the quarterly earnings release has an effect on trading in the days leading up to and after the event. To say that that the quarterly earnings is completely irrelevant in a daily trading environment is an argument I find hard to buy, regardless of the sector or it being a "development stage biotech".

I just want to make money so if i'm totally off base, i'd love to hear why.

If you have some sort of edge based on price movement, which I assume that you think you do, considering you used the words "break out" and "r/r", I don't see why there is any reason to sell because a company is about to report earnings. That is when, if you have any actual edge due to something "breaking out" and this means you have a good "r/r", you would want to hold on.

This is especially true of you think that earnings affect trading in the days leading up to the earnings report. If the move that caught your attention was due to the upcoming earnings report, that would indicate that you shouldn't reduce/eliminate your position.

(TBQH, I don't see it breaking out in any way in the last week, but that is irrelevant to our discussion. It bounced off the lod one time. Maybe that is what you mean)

This why we heart tooth sayer! The fans want a wager booked!!!!

In reference to $IMUN...

I'll try to respond to every comment that was made:

"I base it on looking at what they're trying to sell - a low dose version of an opioid antagonist as a treatment for AIDS. I've looked a lot of pump and dump bio but this one takes the cake for not even trying to look real. It's farcical. There's not even a plausible mechanism of action.

Hence why they're trying to get this clownshow approved in NIGERIA with non-blinded trials (zero possibility for fraud or bribery there)."

The reason why they are starting out in Africa (they hope to start selling in United States within a few years) is because they are going after their target market for AIDS, which is the African population, not the American population (read further for reason why). For other diseases, Americans will be their target market (such as Crohns, multiple sclerosis, and various cancers). Facts about LDN:

-Low-dose naltrexone (LDN) has shown promise in activating your immune system, offering impressive benefit in the treatment of cancer and autoimmune disorders
-LDN is inexpensive and is not backed by any major drug company because potential profits are minimal [exact wordage from mercola.com]. As result, it has not been widely publicized and many physicians are not familiar with it. [big pharma knows about LDN and wants it to fail because it could potentially disrupt their market - if this cheap drug is shown to work more effectively than their expensive drugs]
-LDN does not treat symptoms as most drugs do; it helps regulate bodily mechanisms that can result in a disease state

I'll restate..."potential profits are minimal". LDN will cost a patient $0.84 per day. Of this, IMUN will profit $.24 to the bottom line. This is easily enough to send the stock at least 10x from where it is, so the fact that it is cheap is not a bad things for an investor. The company will still reach profitability this year. Calculations here (I post as dwarren428 on Investors Hub, and am a moderator on that board)...

https://investorshub.advfn.com/board...e_id=131249379

So why going after Africa? Again, they are going after their target market. A pill of LDN costs $.84. Every other drug in this world that treats HIV costs $1000's per month. LDN is the only drug this cheap. Why would IMUN go into United States first? Patients in US have their insurance to pay for these expensive drugs. However, in Western Africa alone, there are 7.5 million people with HIV that are untreated because they can't afford treatment from any of these other expensive drugs. That is who IMUN is going after - an untapped market, with zero competition! I also answered this question here...

https://investorshub.advfn.com/board...e_id=130779298

And Low Dose Naltrexone has already been approved by NAFDAC (Nigerian FDA). LDN passed its final bridging trial in 2016 for HIV in Nigeria (and has also passed multiple Phase 2 studies for various diseases in the United States through its subsidiary Cytocom (in which it owns 55% of). Cytocom doesn't expect sales to begin for a few years. In reference to the bridging trial in Nigeria...

"The Control Group was treated with antiretroviral plus placebo. The primary endpoints were efficacy and safety determined by a minimum increase of 25% in the CD4 count with no adverse effects on quality of life.
The results yielded an average 44% increase in CD4 count in the Treatment Group compared with 11% increase for the Control Group and there was no adverse effect on quality of life or opportunistic infections during the trial. The Nigeria trial’s results were consistent with previous clinical trials of LDN."

This approval in Nigeria will eventually allow them to fastrack into many of the Western 15 or so African states. In my opinion, within 2 years, they'll be in most of those 15 countries. Kenya will be the 2nd most likely.

Of course, the approval of the drug itself (in 2016) was not the final step before commercialization. It has taken another year (which cost the company money of course, hence dilution) to get through all the necessary steps, and now the last step is for NAFDAC to inspect the manufacturing plant in the Dominican Republic, Acromax Dominicana. NAFDAC has already gone to inspect the plant in the D.R. IMUN is just awaiting receipt that the inspection has passed. Once this has happened, IMUN will be granted marketing approval and should begin selling right away. All deals are already in place with Fidson Healthcare in Nigeria (public company FIDSON:NL) from my understanding. Fidson will take care of marketing and we expect 150,000 patients by the 3rd month.


"Here's where you destroy your (tiny) credibility. I mean, we literally have proof of more dilution and possibly predatory lending right here in their filing from 3 days ago:"


In terms of dilution, we are at 287 million outstanding currently, and should finish right around 300 million shares. If you're really worried about that final little bit of dilution (and the market clearly has not been worried about it since 8-k came out on April 13th), then I don't know what to tell you. To each his own. Every stock gets diluted to some degree. ALL PENNY STOCKS are penny stocks for a reason. There was something wrong AT SOME POINT. IMUN is no exception. There was a lot wrong for a long time. That doesn't mean they can't turn around when dilution is over, and we are basically as close to being there as you could imagine. I definitely would not worry about trying to time it any better, because the stock is certainly looking bullish, and we are weeks or a few months from commercialization. Pretty sure the graph has already changed trajectories since April 12/13.

In terms of Ira Gaines' purchase last week...

Ira Gaines purchased 10m shares with a 6 month lockout! That $300k is probably the last cash IMUN will need in my opinion. Once they hit commercialization, all debts will be paid off within a pretty short period (only 9m debt, and should hit 4m in revenue per month by 3rd month). In addition, Ira has a warrant to purchase another 1.5m shares @.15.

This all sounds like good news to me. And it sounds like good news to the market as well (almost all buys to the ask since this 8-k was published, as opposed to sells to the bid), but of course the skeptic doesn't like it. I see that we have a investor willing to buy a huge stake (10m shares), and also agreeing to a 6 month lockout, and those 1.5 million extra shares are worthless if this stock doesn't go up to at least .15 (more than 100% increase from current price). Sounds like good news to me.

You did find things that could concern an investor about Ira Gaines. I would like you to please go into more detail about how exactly this worries you. If Ira buys 10m shares...

1) how exactly is this going to hurt the company's financial stability? It won't, it will help it.
2) how exactly will this stop NAFDAC from granting marketing approval? It won't.
3) how will it stop my shares from being worth much more in a few months when they're at 4m revenue/month? It won't.

I really don't get what you're trying to prove? Did he negotiate some wierd deal that puts him at an advantage? Well, I would say it's possible, but it still won't stop my stock from being worth way more very soon, so it is nothing to be concerned about in my opinion. If there is something I am missing, please elaborate. I would actually like to discuss this further.

"The trouble is, it's bull****. Let's take a little sanity test, shall we? This is what your website claims that a low dose of opioid antagonist can achieve:" [and the website lists 170 or so diseases]

Yes, correct. Again, it TREATS these diseases. Didn't say cure. Didn't say it works exceptionally for all of them [but I dunno, may it is exceptional for all of them]. But why so many anyway? Well they do almost all have ONE THING IN COMMON. Almost all of them are related to the immune system, so are all treated almost the same way. Not all of them are related to the immune system though.

As you said though, it is all irrelevant because LDN is already approved in Nigeria. So who cares if it treats all 170 diseases, right? At least we're good to go on the millions in Africa we'll be treating, with great potential to expand further, as IMUN does own 42 patents related to the drug. Even if it failed in everything else, the stock will still sore on HIV in Nigeria alone.

"So the very guy from your linnk says that there is no money in it (as there usually isn't in non-patentable generics). And that makes it a good thing to invest in...why?"

As I stated above, it doesn't matter. IMUN still making $.24 per pill on millions and millions of pills. They will still be on pace for $13m in annual PROFIT by 3rd month, see link...

https://investorshub.advfn.com/board...e_id=131249379

"This is what I mean about it being a low end pump and dump. It's not even clever. They've merely tagged onto a name that has some google-able details and books behind it, they hit up the forums and do things to get press releases out, and enough people think/do research as you do and swallow the BS that they keep doing secondaries and paying themselves handsome director's fees (they manage to spend $4 million/year, somehow!). It's legal theft, and it's very common; this isn't even a clever example. "

Oh yea, you sure about that? I disagree. I actually know multiple people taking LDN for various ailments, and they swear by it. But of course that means nothing to you. Here is more evidence for you though...

https://www.amazon.com/Promise-Low-D...ose+naltrexone

https://www.amazon.com/LDN-Book-Litt...RMDVB3KN4N1SRZ

https://www.youtube.com/watch?v=Kz52KK5IhOc

https://www.youtube.com/watch?v=FDCn0JWv6Io



If there was anything else that I missed or didn't respond to, it was either because I thought I already addressed it, or if I didn't, then I missed it, and then please restate so I can attempt to address / defend my argument.

"This why we heart tooth sayer! The fans want a wager booked!!!!"

Why would I wager? I guess nobody told me odds yet for a wager, but I'd obviously be getting way better odds (at least in mind) to just put that money in the stock. In my mind, it's going up at least 10x, which nobody is going to give me obviously. Also, I would way rather put the money in this stock then make a bet on the internet with a guy I don't know.

And for those of you claiming "pump and dump", please show me some sort of evidence of any "pumping", mass emails, anything else that's not a legit publication. I don't think you can find anything, but give it a try.

This company is the opposite. They are quiet, not pumping themselves.

Sorry, we dont want any. I would consider your yammering on part of the pump.

Keep an open mind in here or prepare to be bounced by a mod.

The last time it was effectively pumped was 2012.

Currently, it is being pumped by amateurs. Hence "poorly done pump and dump." Type "IMUN" or "$IMUN" into the search bar on twitter.